Skip to main content

Home

Featured

Interviews
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
Interviews
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Presentation
Dr Isabel Newton presents basic guidelines for the use of drug-eluting embolics.
Presentation
Dr Eric Soule presents a "CIO Best Abstract" on OX40, a receptor that causes T-cells to divide, increasing their ability to attack cancer.
Interviews
Tim McClure, MD, discussed biopsy and ablation staging, circumstances in which renal mass biopsy is necessary, and recommendations from guidelines.
Back to Top